Hepatoprotective effect of parthenolide in rat model of nonalcoholic fatty liver disease
Hepatoprotective effect of parthenolide in rat model of nonalcoholic fatty liver disease
复制标题
DOI:
10.1080/08923973.2017.1327965
复制
发表时间:
2017-01-01
影响因子:
3.3
通讯作者:
Khodadadi, Iraj
中科院分区:
文献类型:
--
作者:
Bahabadi, Majid;Mohammadalipour, Adel;Khodadadi, Iraj
Context: The active ingredients of traditional medical herbs have been the focus of scientific interests.Objective: This study was designed to explore the mechanisms of actions of parthenolide on nonalcoholic fatty liver disease (NAFLD).Materials and methods: Thirty-five male Wistar rats were fed high-fat diet (HFD) for eight weeks with or without an intraperitoneal injection of parthenolide to develop NAFLD. Liver triacylglycerol (TG), total antioxidant capacity (TAC), total oxidative status (TOS), thiobarbituric acid reactant substances (TBARs), total thiol groups and tumor necrosis factor alpha (TNF-alpha) and cytochrome P4502E1 (CYP2E1) levels as well as liver ALT, AST and catalase activities were determined. In addition, quantitative real-time PCR was performed to obtain hepatic gene expression levels of TNF-alpha, CYP2E1 and nuclear factor-kappa B (NF-kappa B).Results: HFD caused a significant weight gain and increased liver TG content as well as alteration in ALT and AST activities, which were attenuated after administration of parthenoide (p